Apeiron Therapeutics is a clinical-stage biopharmaceutical and precision oncology company focused on developing biomarker-driven therapeutics for cancer.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Apeiron Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Apeiron Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.
Work at Apeiron Therapeutics? Claim this profile